Literature DB >> 16984620

Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.

Masayuki Shintaku1, Akiko Fukushima.   

Abstract

A surgical case of inflammatory myofibroblastic tumor arising in the uterine corpus and exhibiting prominent myxoid change of the stroma is reported. The patient was a 63-year-old woman with a large tumor mass that filled the uterine cavity and measured 11 cm in maximal dimension. The tumor had a gelatinous appearance and consisted of a loose proliferation of stellate or polygonal cells on a myxomatous background. Fascicular proliferation of spindle cells was also observed focally, and a chronic inflammatory cell infiltration was seen in many areas. Tumor cells had mild atypism and were immunoreactive for vimentin, alpha-smooth muscle actin, and anaplastic lymphoma kinase (ALK). Focal immunoreactivity for high-molecular-weight caldesmon (h-caldesmon) was also noted. The patient has been free from recurrence for 8 months. Inflammatory myofibroblastic tumor of the uterus occasionally shows prominent myxoid change of the stroma, and differentiation from myxoid leiomyosarcoma is problematic in these cases. Based on the immunoreactivity of tumor cells for ALK and h-caldesmon, the present tumor was considered inflammatory myofibroblastic tumor showing a focal phenotypic transition from myofibroblasts to smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984620     DOI: 10.1111/j.1440-1827.2006.02018.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  6 in total

1.  Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.

Authors:  Jennifer A Bennett; Valentina Nardi; Marjan Rouzbahman; Vicente Morales-Oyarvide; G Petur Nielsen; Esther Oliva
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  Inflammatory myofibroblastic tumor of salpinx: a very rare case treated with a less aggressive method.

Authors:  Fatemeh Homaei-Shandiz; Reza Jafarzadeh-Esfehani; Nasrin Moazzen; Amir Amirabadi
Journal:  Iran J Cancer Prev       Date:  2014

3.  Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.

Authors:  Justine L Pickett; Angela Chou; Juliana A Andrici; Adele Clarkson; Loretta Sioson; Amy Sheen; Jessica Reagh; Fedaa Najdawi; Yoomee Kim; Denise Riley; Jayne Maidens; David Nevell; Kirsten McIlroy; Susan Valmadre; Greg Gard; Russell Hogg; John Turchini; Gregory Robertson; Michael Friedlander; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

Review 4.  Uterine inflammatory myofibroblastic tumor: more common than expected: Case report and review.

Authors:  Vincenzo Dario Mandato; Riccardo Valli; Valentina Mastrofilippo; Alessandra Bisagni; Lorenzo Aguzzoli; Giovanni Battista La Sala
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

5.  Extrauterine inflammatory myofibroblastic tumor: A case report.

Authors:  Christina L Kushnir; Melissa Gerardi; Natalie Banet; Ie-Ming Shih; Teresa Diaz-Montes
Journal:  Gynecol Oncol Case Rep       Date:  2013-07-30

6.  Follow-Up Imaging of Inflammatory Myofibroblastic Tumor of the Uterus and Its Spontaneous Regression.

Authors:  Biljana Markovic Vasiljkovic; Vesna Plesinac Karapandzic; Tomislav Pejcic; Aleksandra Djuric Stefanovic; Zorica Milosevic; Snezana Plesinac
Journal:  Iran J Radiol       Date:  2016-01-30       Impact factor: 0.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.